Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Market Research on Methenamine in China 2017-2022 - Research and Markets

Research and Markets
Posted on: 28 Nov 17

The "Market Research on Methenamine in China 2017-2022" report has been added to Research and Markets' offering.

The methenamine industry started relatively late in China and most manufacturers are of small scale and their equipment and techniques are outdated, causing high cost and low operating rate. During the 11th five-year period, along with the fast development of resin and plastics industries, as well as glyphosate, which have further pulled the demand for methenamine. Meanwhile, methenamine becomes more applied in other fields and some enterprises plan to start production lines. In 2012, the output growth rate of methenamine reached two figures.

However, since 2014, for that China becomes more aware of environment protection and published a green reform directive, small methenamine manufacturers faced the risk of being shut down for their low level of techniques and being not environmentally friendly. In 2016, the output of methenamine was about 400,000 tonnes. And related techniques are improved, application field of the product is expanded. For the same year, sales volume of the product reached 400,000 tonnes.

During the first half year in 2017, some methenamine manufacturers in Hebei and Shandong stopped their production or outsourced their orders. Chinese government has made green reform more clear and greater attention has paid to the reform. At the beginning of 2017, methenamine was officially included on the list of hazardous chemicals liable to produce explosives, which brings challenges to manufacturers and opportunities to high-tech manufacturers. Generally, during the 13th five-year period, the output of methenamine will slow down and is forecasted to be 543,000 tonnes in 2022. As for sales, about 540,000 tonnes methenamine will be sold in 2022.

Key Topics Covered:

Executive Summary


1 Development Environment for Methenamine Industry in China

1.1 Economy

1.2 Policy

2 General Status of China Methenamine Market

2.1 Supply

2.1.1 Output

2.1.2 Manufacturers

2.2 Demand

2.3 Price

2.4 Customers

2.4.1 Customers in Jiangsu

2.4.2 Customers in Zhejiang

2.4.3 Customers in Shanghai

3 Industrial Chain of Methenamine Industry in China

3.1 Upstream

3.1.1 Formaldehyde

3.1.2 Synthetic Ammonia

3.2 Downstream

3.2.1 Phenolic Resin

3.2.2 Rubber and Plastics

3.2.3 Pharmaceutical Industry

4 Analysis of Key Methenamine Manufacturers in China

4.1 Sislan Pharmaceutical Co., Ltd.

4.2 Ruixng Group

4.3 Yangmei Fengxi Fertilizer Industry (Group) Co., Ltd.

4.4 Hebei Xinhua Co., Ltd.

4.3 Lanzhou Zhongkai Industrial Trading Co., Ltd.

5 Forecast and Investment Suggestions of Methenamine Industry in China, 2017-2022

5.1 Forecast

5.2 Investment Suggestion

5.2.1 Meaning of Strategy Planning

5.2.2 Principles of Strategy Planning

5.2.3 Analysis on Strategy Planning

5.2.4 Key Customer Strategy

Companies Mentioned

  • Hebei Xinhua Co., Ltd.
  • Lanzhou Zhongkai Industrial Trading Co., Ltd.
  • Ruixng Group
  • Sislan Pharmaceutical Co., Ltd.
  • Yangmei Fengxi Fertilizer Industry (Group) Co., Ltd.

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.